X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (956) 956
Publication (225) 225
Paper (210) 210
Report (124) 124
Patent (94) 94
Book / eBook (5) 5
Book Review (5) 5
Data Set (4) 4
Conference Proceeding (3) 3
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cern lhc coll (395) 395
experimental results (386) 386
p p: scattering (322) 322
13000 gev-cms (310) 310
p p: colliding beams (296) 296
humans (294) 294
physics (259) 259
experiment (246) 246
high energy physics - experiment (234) 234
cms (233) 233
particle physics (209) 209
high energy physics (207) 207
physics - high energy physics - experiment (203) 203
index medicus (202) 202
hep (199) 199
hematology (183) 183
male (157) 157
female (154) 154
phenomenology (151) 151
middle aged (132) 132
aged (131) 131
background (123) 123
multiple myeloma (118) 118
scattering [p p] (115) 115
oncology (113) 113
physics of elementary particles and fields (112) 112
multiple myeloma - drug therapy (111) 111
adult (106) 106
bortezomib (106) 106
colliding beams [p p] (106) 106
ex (101) 101
hadron-hadron scattering (86) 86
antineoplastic combined chemotherapy protocols - therapeutic use (82) 82
channel cross section: upper limit (81) 81
nuclear experiment (76) 76
transverse momentum: missing-energy (76) 76
treatment outcome (73) 73
cern lab (72) 72
prognosis (72) 72
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (67) 67
mass dependence (65) 65
supersymmetry (59) 59
dexamethasone (58) 58
final state:jet lepton (57) 57
aged, 80 and over (55) 55
antineoplastic agents - therapeutic use (54) 54
channel cross section: branching ratio: upper limit (54) 54
therapy (54) 54
survival (53) 53
thalidomide (53) 53
bottom: particle identification (51) 51
stem-cell transplantation (51) 51
abridged index medicus (48) 48
muon: pair production (48) 48
multiple myeloma - mortality (47) 47
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (46) 46
cancer (46) 46
top: pair production (46) 46
kinematics (45) 45
data analysis method (44) 44
higgs particle: hadroproduction (43) 43
transverse momentum dependence (43) 43
z0: leptonic decay (43) 43
final state:jet dilepton (42) 42
jet: bottom (42) 42
care and treatment (41) 41
disease-free survival (41) 41
human necessities (40) 40
microbiology (40) 40
multiple myeloma - genetics (40) 40
114 physical sciences (38) 38
bottom: pair production (38) 38
recurrence (38) 38
beer (37) 37
biochemistry (37) 37
chemistry (37) 37
chemotherapy (37) 37
compositions or test papers therefor (37) 37
condition-responsive control in microbiological orenzymological processes (37) 37
enzymology (37) 37
measuring or testing processes involving enzymes, nucleicacids or microorganisms (37) 37
metallurgy (37) 37
multiple myeloma - pathology (37) 37
mutation or genetic engineering (37) 37
processes of preparing such compositions (37) 37
spirits (37) 37
vinegar (37) 37
wine (37) 37
general tagging of cross-sectional technologies spanning over several sections of the ipc (36) 36
general tagging of new technological developments (36) 36
lenalidomide (36) 36
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (36) 36
technologies or applications for mitigation or adaptation againstclimate change (36) 36
hematology, oncology and palliative medicine (35) 35
8000 gev-cms (34) 34
channel cross section: measured (34) 34
multiple myeloma - therapy (34) 34
resonance: production (34) 34
survival analysis (34) 34
adolescent (33) 33
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Art - Welsh/Mondrian (1) 1
Gerstein Science - Stacks (1) 1
Robarts - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1182) 1182
French (34) 34
German (22) 22
Spanish (8) 8
Dutch (6) 6
Portuguese (4) 4
Chinese (2) 2
Czech (1) 1
Danish (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hematology, ISSN 1520-4391, 12/2017, Volume 2017, Issue 1, pp. 508 - 517
Abstract The approach to the patient with relapsed or relapsed/refractory multiple myeloma requires a careful evaluation of the results of previous treatments,... 
Index Medicus
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 12/2017, Volume 2017, Issue 1, pp. 508 - 517
The approach to the patient with relapsed or relapsed/refractory multiple myeloma requires a careful evaluation of the results of previous treatments, the... 
Novel Therapeutics in Myeloma
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 11, pp. 1055 - 1066
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 11, pp. 1057 - 1065
Summary Background Bortezomib-induced peripheral neuropathy is a dose-limiting toxicity in patients with multiple myeloma, often requiring adjustment of... 
Hematology, Oncology and Palliative Medicine | APOPTOSIS | DEXAMETHASONE | EFFICACY | ONCOLOGY | REFRACTORY MYELOMA | PHASE-II | INDUCTION | STEM-CELL TRANSPLANTATION | NEUROTOXICITY | CANCER | LINES | Peripheral Nervous System Diseases - chemically induced | Prospective Studies | Humans | Middle Aged | Boronic Acids - adverse effects | Gene Expression Profiling | Young Adult | Multiple Myeloma - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Adult | Odds Ratio | Peripheral Nervous System Diseases - genetics | Genetic Predisposition to Disease | Bortezomib | Multiple Myeloma - diagnosis | Risk Assessment | Europe | Gene Frequency | Risk Factors | Treatment Outcome | Chi-Square Distribution | Adolescent | Pyrazines - adverse effects | Vincristine - adverse effects | Aged | Polymorphism, Single Nucleotide | Neoplasm Staging | Multiple Myeloma - genetics | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Multiple myeloma | Toxicity | Clinical trials | Nervous system | Superoxide dismutase | Single-nucleotide polymorphism | Myeloma | Peripheral neuropathy | DNA repair | Mitochondria | Coding | Cell cycle | Peripheral blood | Age | Peripheral nervous system | Enzymes | Excretion | Data processing | Inflammation | Gene expression | Metabolism | Vincristine | Quality of life | Queens | Caspase-9 | Plasma cells | Peroxisome proliferator-activated receptors | Apoptosis | Cancer
Journal Article
Leukemia, ISSN 0887-6924, 04/2014, Volume 28, Issue 11, pp. 2229 - 2234
With advent of several treatment options in multiple myeloma (MM), a selection of effective regimen has become an important issue. Use of gene expression... 
INTERGROUPE FRANCOPHONE | BREAST-CANCER | MOLECULAR CLASSIFICATION | ONCOLOGY | LENALIDOMIDE PLUS DEXAMETHASONE | THERAPEUTIC TARGETS | FOLLOW-UP | BORTEZOMIB | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MICROARRAY DATA | CHEMOTHERAPY | Usage | Genetic aspects | Gene expression | Multiple myeloma | multiple myeloma | response prediction | gene expression signature
Journal Article
Journal Article
Journal Article
Journal Article